Everything on Healthcare/Biotech

Revolution Medicines' drug for pancreatic cancer nearly doubled the average survival time in a Phase 3 study, potentially creating a 5 billion USD revenue opportunity in the US alone.

Impact: Could significantly shift the standard of care for pancreatic cancer and result in a massive valuation increase for the company.

— from Market Volatility Profits, Luxury Assets and Strategic Shifts · OHNE AKTIEN WIRD SCHWER - Tägliche Börsen-News· Apr 14, 2026

AI-driven drug discovery can be automated from design through toxicity checking, eventually reducing reliance on traditional clinical trial timelines.

Impact: Drastically reduces the cost and time to bring life-saving medications to market, creating massive value in the biotech sector.

— from Demis Hassabis on AGI Timelines, AI Safety, and Scientific Revolution · The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch· Apr 07, 2026